WATCH PRESENTATION
Innovations Across the Cell Therapy Workflow: From Apheresis to Analysis
AABB 2025 (Association for the Advancement of Blood & Biotherapies)
Description: As demand for cellular starting material for cell therapy grows, new approaches are emerging to improve access, efficiency, and quality in cell collection. Some of the topics discussed during this AABB Biotherapies Pavilion open-mic panel session include:
- Deeper cellular starting material characterization: The need for faster, standardized immunophenotyping of leukapheresis products at the point of collection to reduce variability and provide earlier actionable insights for autologous and allogeneic cell therapy manufacturing.
- Smarter, more predictable collections: How combining apheresis collection data with real-time cellular readouts enables mid-collection adjustments and can be applied to improving first-pass success and better aligning collection decisions with downstream manufacturing needs.
- Seamless data integration across the cell therapies collections workflow: The demand for seamless integration across devices and software, real-time data capture without manual entry, configurable workflows for diverse sponsors, and the growing role of AI in accelerating calculations and improving data quality.
If you are a blood collection center or a cell therapy developer and didn’t get the opportunity to attend this AABB open mic session, you can now view this panel discussion on demand.
